Preoperative Bilirubin-Adjusted Carbohydrate Antigen 19-9 as a Prognostic Factor for Extrahepatic Cholangiocarcinoma Patients at a Single Center.

Jiayi Li Qiao ChenBao JinYue ShiXiangan WuHaifeng XuYongchang ZhengYingyi WangShunda DuXin LuYilei MaoXinting Sang

Published in: Cancer management and research (2020)

The preoperative CA19-9/BR ratio is a good prognostic factor in predicting survival in ECC patients and closer follow-up is recommended in patients with a higher CA19-9/BR ratio before surgery.

Keyphrases

prognostic factors
patients undergoing
minimally invasive
end stage renal disease
coronary artery bypass
protein kinase
newly diagnosed
ejection fraction
acute coronary syndrome
peritoneal dialysis
percutaneous coronary intervention